Parameters | P value | HR | HR(95% CI) |
---|---|---|---|
Model 1:FSGS+ and aFSL+ groups as one group (FSL+ group) | |||
 Age ≥ 60 years | 0.003 | 2.602 | 1.373–4.930 |
 Hypertension | 0.127 | 1.874 | 0.837–4.192 |
 eGFR< 60(ml/min per 1.73m2) | 0.009 | 2.632 | 1.279–5.415 |
 FSL (FSGS,aFSL = 1,FSL− = 0) | 0.251 | 1.557 | 0.731–3.320 |
 Global Glomerulosclerosis (> 5%) | 0.278 | 1.548 | 0.703–3.410 |
 Proliferation of mesangial (stage1,2,3 = 1) | 0.648 | 1.178 | 0.582–2.383 |
 Tubulointerstitial fibrosis (area ≥ 15% = 1) | 0.003 | 3.008 | 1.470–6.156 |
 Vascular sclerosis (stage1,2,3 = 1) | 0.267 | 2.293 | 0.530–9.921 |
Moldel 2:FSGS+ and aFSL+ groups as two individual groups | |||
 Age ≥ 60 years | 0.001 | 2.870 | 1.519–5.424 |
 Hypertension | 0.182 | 1.741 | 0.771–3.930 |
 eGFR< 60(ml/min per 1.73m2) | 0.003 | 2.925 | 1.441–5.936 |
FSL | |||
 FSL− |  |  | 1.00 (referent) |
 FSGS | 0.026 | 2.471 | 1.113–5.486 |
 aFSL | 0.260 | 0.503 | 0.152–1.663 |
Global Glomerulosclerosis (> 5%) | 0.338 | 1.467 | 0.669–3.215 |
Proliferation of mesangial (stage 1,2,3 = 1) | 0.894 | 1.049 | 0.518–2.122 |
Tubulointerstitial fibrosis (area ≥ 15% = 1) | 0.010 | 2.553 | 1.248–5.224 |
Vascular sclerosis (stage 1,2,3 = 1) | 0.351 | 2.014 | 0.462–8.770 |